These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1009 related articles for article (PubMed ID: 28182533)

  • 1. The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings.
    Münter KC; Meaume S; Augustin M; Senet P; Kérihuel JC
    J Wound Care; 2017 Feb; 26(Sup2):S4-S15. PubMed ID: 28182533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal wound closure of diabetic foot ulcers with early initiation of TLC-NOSF treatment: post-hoc analysis of Explorer.
    Lázaro-Martínez JL; Edmonds M; Rayman G; Apelqvist J; Van Acker K; Hartemann A; Martini J; Lobmann R; Bohbot S; Kerihuel JC; Piaggesi A
    J Wound Care; 2019 Jun; 28(6):358-367. PubMed ID: 31166858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of UrgoStart Plus dressings in real-life conditions: results of a prospective multicentre study on 961 patients.
    Augustin M; Keuthage W; Lobmann R; Lützkendorf S; Groth H; Möller U; Thomassin L; Bohbot S; Dissemond J; Blome C
    J Wound Care; 2021 Dec; 30(12):966-978. PubMed ID: 34881999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of polyabsorbent TLC-NOSF dressings on chronic wounds: a prospective, observational, multicentre study of 1140 patients.
    Dissemond J; Lützkendorf S; Dietlein M; Neßeler I; Becker E; Möller U; Thomassin L; Bohbot S; Münter KC
    J Wound Care; 2020 Jun; 29(6):350-361. PubMed ID: 32530781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of primary dressings on healing of venous leg ulcers: a French cohort study from the healthcare insurance database.
    Meaume S; Senet P; Thomé B; Aragno VA; Serge B; Fortin S; Boucley I; Michon-Pasturel U; Colboc H
    J Wound Care; 2024 Sep; 33(9):678-686. PubMed ID: 39287032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in patients with leg ulcers: results from CHALLENGE, a double-blind randomised controlled trial.
    Meaume S; Dompmartin A; Lok C; Lazareth I; Sigal M; Truchetet F; Sauvadet A; Bohbot S;
    J Wound Care; 2017 Jul; 26(7):368-379. PubMed ID: 28704156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLC-NOSF dressings as a first-line local treatment of chronic wounds: a systematic review of clinical evidence.
    Meloni M; Colboc H; Armstrong DG; Dissemond J; Rayman G; Lázaro-Martínez JL; Rial R; Hartemann A; Atkin L; Swanson T; Goodeve M; Lobmann R; Storck M; Kröger K; Borys S; Nair HK; Vaidya S; Tran TN; Huynh BLT; Thomassin L; Bohbot S; Manu C; Meaume S
    J Wound Care; 2024 Oct; 33(10):756-770. PubMed ID: 39388207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of sucrose octasulfate (TLC-NOSF) dressings in the treatment of chronic wounds: a systematic review.
    Nair H; Venkateshwaran N; Seetharaman S S; Deng W; Uthaipaisanwong A; Galea E
    J Wound Care; 2021 Apr; 30(Sup4):S42-S52. PubMed ID: 33856929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of MMP-inhibiting wound dressings in the treatment of chronic wounds: a systematic review.
    Dissemond J; Augustin M; Dietlein M; Faust U; Keuthage W; Lobmann R; Münter KC; Strohal R; Stücker M; Traber J; Vanscheidt W; Läuchli S
    J Wound Care; 2020 Feb; 29(2):102-118. PubMed ID: 32058850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of TLC-NOSF dressing with poly-absorbent fibres in exuding leg ulcers: two multicentric, single-arm, prospective, open-label clinical trials.
    Sigal ML; Addala A; Maillard H; Chahim M; Sala F; Blaise S; Dalac S; Meaume S; Bohbot S; Tumba C; Tacca O
    J Wound Care; 2019 Mar; 28(3):164-175. PubMed ID: 30840551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France.
    Maunoury F; Oury A; Fortin S; Thomassin L; Bohbot S;
    PLoS One; 2021; 16(1):e0245652. PubMed ID: 33481840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial.
    Schmutz JL; Meaume S; Fays S; Ourabah Z; Guillot B; Thirion V; Collier M; Barrett S; Smith J; Bohbot S; Dompmartin A
    Int Wound J; 2008 Jun; 5(2):172-82. PubMed ID: 18494623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical cases about the therapeutic use of debriding dressing hidrodetersive polyacrylate fibers with TLC and foam dressings TLC-NOSF polyurethane in chronic wounds].
    Blasco García C; Segovia Gómez T; Bermejo Martínez M; Cuesta Cuesta JJ; Alventosa Cortés AM
    Rev Enferm; 2012 Oct; 35(10):9-14. PubMed ID: 23157065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of autologous punch grafting, TLC-NOSF dressing and multitype compression therapy to rapidly achieve wound closure in hard-to-heal venous leg ulcers.
    Conde-Montero E; Bohbot S; Grado Sanz R; Peral Vázquez A; Recarte-Marín L; Pérez-Jerónimo L; Galán Sánchez JL; de la Cueva Dobao P
    J Med Vasc; 2020 Dec; 45(6):316-325. PubMed ID: 33248534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Ovine-based Collagen Extracellular Matrix and Gentian Violet/Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds: A Retrospective Cohort Study.
    Lullove EJ
    Wounds; 2017 Apr; 29(4):107-114. PubMed ID: 28448264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: the EUREKA trial.
    Romanelli M; Piaggesi A; Scapagnini G; Dini V; Janowska A; Iacopi E; Scarpa C; Fauverghe S; Bassetto F;
    J Wound Care; 2018 Nov; 27(11):744-753. PubMed ID: 30398941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success.
    Saco M; Howe N; Nathoo R; Cherpelis B
    Dermatol Online J; 2016 Aug; 22(8):. PubMed ID: 27617934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of diabetic foot ulcers with a TLC-NOSF wound dressing.
    Richard JL; Martini J; Bonello Faraill MM; Bemba JM; Lepeut M; Truchetet F; Ehrler S; Schuldiner S; Sauvadet A; Bohbot S
    J Wound Care; 2012 Mar; 21(3):142-7. PubMed ID: 22399083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers.
    Meaume S; Truchetet F; Cambazard F; Lok C; Debure C; Dalac S; Lazareth I; Sigal ML; Sauvadet A; Bohbot S; Dompmartin A;
    Wound Repair Regen; 2012; 20(4):500-11. PubMed ID: 22681551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of treating vascular leg ulcers with UrgoStart(®) and UrgoCell(®) Contact.
    Augustin M; Herberger K; Kroeger K; Muenter KC; Goepel L; Rychlik R
    Int Wound J; 2016 Feb; 13(1):82-7. PubMed ID: 24618370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.